Annual report
3645.TEDINET S100RS9E
Period2022-06-01 → 2023-05-31
Filed2023-08-31
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 148
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥4.5bn | 2022-06-01 → 2023-05-31 | Cons. | Net sales |
| Revenue | ¥3.7bn | 2021-06-01 → 2022-05-31 | Cons. | Net sales |
| Revenue | ¥2.9bn | 2020-06-01 → 2021-05-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥2.6bn | 2019-06-01 → 2020-05-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥2.0bn | 2018-06-01 → 2019-05-31d | Cons. | Net sales (5-year summary) |
| Operating income | ¥380m | 2022-06-01 → 2023-05-31 | Cons. | Operating income |
| Operating income | ¥445m | 2021-06-01 → 2022-05-31 | Cons. | Operating income |
| Ordinary income | ¥432m | 2022-06-01 → 2023-05-31 | Cons. | Ordinary income |
| Ordinary income | ¥450m | 2021-06-01 → 2022-05-31 | Cons. | Ordinary income |
| Ordinary income | ¥336m | 2020-06-01 → 2021-05-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥104m | 2019-06-01 → 2020-05-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥183m | 2018-06-01 → 2019-05-31d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥251m | 2022-06-01 → 2023-05-31 | Cons. | Income before income taxes |
| Profit before tax | ¥534m | 2021-06-01 → 2022-05-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥116m | 2022-06-01 → 2023-05-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥380m | 2021-06-01 → 2022-05-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥130m | 2020-06-01 → 2021-05-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥79m | 2019-06-01 → 2020-05-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥102m | 2018-06-01 → 2019-05-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥109m | 2022-06-01 → 2023-05-31 | Cons. | Profit loss |
| Net income | ¥396m | 2021-06-01 → 2022-05-31 | Cons. | Profit loss |
| Total assets | ¥3.5bn | at 2023-05-31 | Cons. | Assets |
| Total assets | ¥3.1bn | at 2022-05-31 | Cons. | Assets |
| Total assets | ¥2.1bn | at 2021-05-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥1.7bn | at 2020-05-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥2.1bn | at 2019-05-31d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥1.5bn | at 2023-05-31 | Cons. | Liabilities |
| Total liabilities | ¥1.4bn | at 2022-05-31 | Cons. | Liabilities |
| Net assets / equity | ¥1.9bn | at 2023-05-31 | Cons. | Net assets |
| Net assets / equity | ¥1.7bn | at 2022-05-31 | Cons. | Net assets |
| Net assets / equity | ¥1.3bn | at 2021-05-31d | Cons. | Net assets |
| Net assets / equity | ¥1.0bn | at 2020-05-31d | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥1.6bn | at 2019-05-31d | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥1.5bn | at 2023-05-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥1.1bn | at 2022-05-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥1.5bn | at 2023-05-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.1bn | at 2022-05-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥869m | at 2021-05-31d | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥596m | at 2020-05-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥1.0bn | at 2019-05-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥429m | 2022-06-01 → 2023-05-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥343m | 2021-06-01 → 2022-05-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥392m | 2020-06-01 → 2021-05-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥78m | 2019-06-01 → 2020-05-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥22m | 2018-06-01 → 2019-05-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥62m | 2022-06-01 → 2023-05-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥355m | 2021-06-01 → 2022-05-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥88m | 2020-06-01 → 2021-05-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥15m | 2019-06-01 → 2020-05-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥145m | 2018-06-01 → 2019-05-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥18m | 2022-06-01 → 2023-05-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥282m | 2021-06-01 → 2022-05-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥34m | 2020-06-01 → 2021-05-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥497m | 2019-06-01 → 2020-05-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥21m | 2018-06-01 → 2019-05-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥12.97 | 2022-06-01 → 2023-05-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥43.44 | 2021-06-01 → 2022-05-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥15.36 | 2020-06-01 → 2021-05-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥9.26 | 2019-06-01 → 2020-05-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥9.49 | 2018-06-01 → 2019-05-31d | Cons. | Basic earnings loss per share (5-year summary) |
| Net assets per share | ¥211.94 | at 2023-05-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥193.19 | at 2022-05-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥144.23 | at 2021-05-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥123.32 | at 2020-05-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥151.83 | at 2019-05-31d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 55.3% | at 2023-05-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 54.1% | at 2022-05-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 59.0% | at 2021-05-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 57.4% | at 2020-05-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 79.7% | at 2019-05-31d | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 6.4% | 2022-06-01 → 2023-05-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 25.8% | 2021-06-01 → 2022-05-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 11.6% | 2020-06-01 → 2021-05-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 6.0% | 2019-06-01 → 2020-05-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 6.4% | 2018-06-01 → 2019-05-31d | Cons. | Rate of return on equity (5-year summary) |
| Employees | 186 | at 2023-05-31 | Cons. | Number of employees |
| Employees | 163 | at 2022-05-31 | Cons. | Number of employees |
| Employees | 113 | at 2021-05-31d | Cons. | Number of employees |
| Employees | 110 | at 2020-05-31d | Cons. | Number of employees |
| Employees | 102 | at 2019-05-31d | Cons. | Number of employees |
| Revenue | ¥1.8bn | 2022-06-01 → 2023-05-31 | Standalone | Net sales |
| Revenue | ¥1.6bn | 2021-06-01 → 2022-05-31 | Standalone | Net sales |
| Revenue | ¥1.4bn | 2020-06-01 → 2021-05-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥1.2bn | 2019-06-01 → 2020-05-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥1.3bn | 2018-06-01 → 2019-05-31d | Standalone | Net sales (5-year summary) |
| Operating income | ¥344m | 2022-06-01 → 2023-05-31 | Standalone | Operating income |
| Operating income | ¥365m | 2021-06-01 → 2022-05-31 | Standalone | Operating income |
| Ordinary income | ¥403m | 2022-06-01 → 2023-05-31 | Standalone | Ordinary income |
| Ordinary income | ¥352m | 2021-06-01 → 2022-05-31 | Standalone | Ordinary income |
| Ordinary income | ¥322m | 2020-06-01 → 2021-05-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥97m | 2019-06-01 → 2020-05-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥237m | 2018-06-01 → 2019-05-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥333m | 2022-06-01 → 2023-05-31 | Standalone | Income before income taxes |
| Profit before tax | ¥351m | 2021-06-01 → 2022-05-31 | Standalone | Income before income taxes |
| Net income | ¥214m | 2022-06-01 → 2023-05-31 | Standalone | Profit loss |
| Net income | ¥248m | 2021-06-01 → 2022-05-31 | Standalone | Profit loss |
| Net income | ¥137m | 2020-06-01 → 2021-05-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥70m | 2019-06-01 → 2020-05-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥49m | 2018-06-01 → 2019-05-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥2.8bn | at 2023-05-31 | Standalone | Assets |
| Total assets | ¥2.5bn | at 2022-05-31 | Standalone | Assets |
| Total assets | ¥1.8bn | at 2021-05-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥1.5bn | at 2020-05-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥1.9bn | at 2019-05-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥944m | at 2023-05-31 | Standalone | Liabilities |
| Total liabilities | ¥929m | at 2022-05-31 | Standalone | Liabilities |
| Net assets / equity | ¥1.9bn | at 2023-05-31 | Standalone | Net assets |
| Net assets / equity | ¥1.6bn | at 2022-05-31 | Standalone | Net assets |
| Net assets / equity | ¥1.3bn | at 2021-05-31d | Standalone | Net assets |
| Net assets / equity | ¥1.0bn | at 2020-05-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥1.7bn | at 2019-05-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥1.1bn | at 2023-05-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥798m | at 2022-05-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥23.89 | 2022-06-01 → 2023-05-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥28.4 | 2021-06-01 → 2022-05-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥16.23 | 2020-06-01 → 2021-05-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥8.2 | 2019-06-01 → 2020-05-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥4.56 | 2018-06-01 → 2019-05-31d | Standalone | Basic earnings loss per share (5-year summary) |
| Dividend per share | ¥2.5 | 2022-06-01 → 2023-05-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥4 | 2021-06-01 → 2022-05-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥4 | 2020-06-01 → 2021-05-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥1.5 | 2019-06-01 → 2020-05-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥2 | 2018-06-01 → 2019-05-31d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥209.76 | at 2023-05-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥181.56 | at 2022-05-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥148.43 | at 2021-05-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥127.15 | at 2020-05-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥155.37 | at 2019-05-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 66.8% | at 2023-05-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 63.3% | at 2022-05-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 69.9% | at 2021-05-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 66.8% | at 2020-05-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 89.4% | at 2019-05-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 12.2% | 2022-06-01 → 2023-05-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 17.3% | 2021-06-01 → 2022-05-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 11.9% | 2020-06-01 → 2021-05-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 5.2% | 2019-06-01 → 2020-05-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 3.0% | 2018-06-01 → 2019-05-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 10,773,000 | at 2023-05-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 10,773,000 | at 2022-05-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 10,773,000 | at 2021-05-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 10,773,000 | at 2020-05-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 10,773,000 | at 2019-05-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 114 | at 2023-05-31 | Standalone | Number of employees |
| Employees | 98 | at 2022-05-31 | Standalone | Number of employees |
| Employees | 89 | at 2021-05-31d | Standalone | Number of employees |
| Employees | 93 | at 2020-05-31d | Standalone | Number of employees |
| Employees | 79 | at 2019-05-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 77
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2022-06-01 → 2023-05-31 | ¥4m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2022-06-01 → 2023-05-31 | ¥4m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2022-06-01 → 2023-05-31 | ¥4m |
| Mediaplatformreportable segment | depreciation | 2022-06-01 → 2023-05-31 | ¥1m |
| Mediaplatformreportable segment | employees | at 2023-05-31 | 30 pure |
| Mediaplatformreportable segment | revenue | 2022-06-01 → 2023-05-31 | ¥1.1bn |
| Mediaplatformreportable segment | revenue external | 2022-06-01 → 2023-05-31 | ¥1.1bn |
| Mediaplatformreportable segment | revenue intersegment | 2022-06-01 → 2023-05-31 | ¥2,000 |
| Mediaplatformreportable segment | segment assets | at 2023-05-31 | ¥80m |
| Mediaplatformreportable segment | segment profit | 2022-06-01 → 2023-05-31 | ¥629m |
| Medical B To Breportable segment | depreciation | 2022-06-01 → 2023-05-31 | ¥523,000 |
| Medical B To Breportable segment | employees | at 2023-05-31 | 11 pure |
| Medical B To Breportable segment | revenue | 2022-06-01 → 2023-05-31 | ¥182m |
| Medical B To Breportable segment | revenue external | 2022-06-01 → 2023-05-31 | ¥182m |
| Medical B To Breportable segment | revenue intersegment | 2022-06-01 → 2023-05-31 | ¥22,000 |
| Medical B To Breportable segment | segment assets | at 2023-05-31 | ¥35m |
| Medical B To Breportable segment | segment profit | 2022-06-01 → 2023-05-31 | ¥50m |
| Medical Institution Management Supportreportable segment | capex | 2022-06-01 → 2023-05-31 | ¥14m |
| Medical Institution Management Supportreportable segment | depreciation | 2022-06-01 → 2023-05-31 | ¥12m |
| Medical Institution Management Supportreportable segment | employees | at 2023-05-31 | 120 pure |
| Medical Institution Management Supportreportable segment | revenue | 2022-06-01 → 2023-05-31 | ¥3.3bn |
| Medical Institution Management Supportreportable segment | revenue external | 2022-06-01 → 2023-05-31 | ¥3.3bn |
| Medical Institution Management Supportreportable segment | revenue intersegment | 2022-06-01 → 2023-05-31 | ¥213,000 |
| Medical Institution Management Supportreportable segment | segment assets | at 2023-05-31 | ¥2.2bn |
| Medical Institution Management Supportreportable segment | segment profit | 2022-06-01 → 2023-05-31 | ¥148m |
| —segment total | capex | 2022-06-01 → 2023-05-31 | ¥14m |
| —segment total | depreciation | 2022-06-01 → 2023-05-31 | ¥14m |
| —segment total | revenue | 2022-06-01 → 2023-05-31 | ¥4.5bn |
| —segment total | revenue external | 2022-06-01 → 2023-05-31 | ¥4.5bn |
| —segment total | revenue intersegment | 2022-06-01 → 2023-05-31 | ¥237,000 |
| —segment total | segment assets | at 2023-05-31 | ¥2.3bn |
| —segment total | segment profit | 2022-06-01 → 2023-05-31 | ¥826m |
| Total Of Reportable Segments And Otherssegment total | capex | 2022-06-01 → 2023-05-31 | ¥14m |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2022-06-01 → 2023-05-31 | ¥14m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-06-01 → 2023-05-31 | ¥4.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-06-01 → 2023-05-31 | ¥4.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-06-01 → 2023-05-31 | ¥237,000 |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2023-05-31 | ¥2.3bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-06-01 → 2023-05-31 | ¥830m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2021-06-01 → 2022-05-31 | ¥4m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2021-06-01 → 2022-05-31 | ¥4m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2021-06-01 → 2022-05-31 | ¥4m |
| Mediaplatformreportable segment | depreciation | 2021-06-01 → 2022-05-31 | ¥2m |
| Mediaplatformreportable segment | revenue | 2021-06-01 → 2022-05-31 | ¥994m |
| Mediaplatformreportable segment | revenue external | 2021-06-01 → 2022-05-31 | ¥994m |
| Mediaplatformreportable segment | segment assets | at 2022-05-31 | ¥72m |
| Mediaplatformreportable segment | segment profit | 2021-06-01 → 2022-05-31 | ¥616m |
| Medical B To Breportable segment | depreciation | 2021-06-01 → 2022-05-31 | ¥441,000 |
| Medical B To Breportable segment | revenue | 2021-06-01 → 2022-05-31 | ¥169m |
| Medical B To Breportable segment | revenue external | 2021-06-01 → 2022-05-31 | ¥169m |
| Medical B To Breportable segment | revenue intersegment | 2021-06-01 → 2022-05-31 | ¥17,000 |
| Medical B To Breportable segment | segment assets | at 2022-05-31 | ¥19m |
| Medical B To Breportable segment | segment profit | 2021-06-01 → 2022-05-31 | ¥58m |
| Medical Institution Management Supportreportable segment | capex | 2021-06-01 → 2022-05-31 | ¥2m |
| Medical Institution Management Supportreportable segment | depreciation | 2021-06-01 → 2022-05-31 | ¥10m |
| Medical Institution Management Supportreportable segment | revenue | 2021-06-01 → 2022-05-31 | ¥2.6bn |
| Medical Institution Management Supportreportable segment | revenue external | 2021-06-01 → 2022-05-31 | ¥2.6bn |
| Medical Institution Management Supportreportable segment | revenue intersegment | 2021-06-01 → 2022-05-31 | ¥888,000 |
| Medical Institution Management Supportreportable segment | segment assets | at 2022-05-31 | ¥2.3bn |
| Medical Institution Management Supportreportable segment | segment profit | 2021-06-01 → 2022-05-31 | ¥203m |
| —segment total | capex | 2021-06-01 → 2022-05-31 | ¥2m |
| —segment total | depreciation | 2021-06-01 → 2022-05-31 | ¥12m |
| —segment total | revenue | 2021-06-01 → 2022-05-31 | ¥3.7bn |
| —segment total | revenue external | 2021-06-01 → 2022-05-31 | ¥3.7bn |
| —segment total | revenue intersegment | 2021-06-01 → 2022-05-31 | ¥906,000 |
| —segment total | segment assets | at 2022-05-31 | ¥2.4bn |
| —segment total | segment profit | 2021-06-01 → 2022-05-31 | ¥878m |
| Total Of Reportable Segments And Otherssegment total | capex | 2021-06-01 → 2022-05-31 | ¥2m |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2021-06-01 → 2022-05-31 | ¥12m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-06-01 → 2022-05-31 | ¥3.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-06-01 → 2022-05-31 | ¥3.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2021-06-01 → 2022-05-31 | ¥906,000 |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2022-05-31 | ¥2.4bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2021-06-01 → 2022-05-31 | ¥881m |
| Mediaplatformreportable segment | employees | at 2023-05-31 | 30 pure |
| Medical B To Breportable segment | employees | at 2023-05-31 | 11 pure |
| Medical Institution Management Supportreportable segment | employees | at 2023-05-31 | 48 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,388
| Item | Context | Value | Unit |
|---|---|---|---|
| Foreign currency translation adjustment | CurrentYearInstant | 24689000 | JPY |
| Valuation and translation adjustments | Prior1YearInstant | 11303000 | JPY |
| Valuation and translation adjustments | CurrentYearInstant | 26919000 | JPY |
| Non controlling interests | Prior1YearInstant | 29609000 | JPY |
| Non controlling interests | CurrentYearInstant | 12002000 | JPY |
| Net assets | Prior1YearInstant | 1732766000 | JPY |
| Net assets | CurrentYearInstant | 1929020000 | JPY |
| Liabilities and net assets | Prior1YearInstant | 3149675000 | JPY |
| Liabilities and net assets | CurrentYearInstant | 3467360000 | JPY |
| Net sales | Prior1YearDuration | 3745765000 | JPY |
| Net sales | CurrentYearDuration | 4500846000 | JPY |
| Cost of sales | Prior1YearDuration | 2285724000 | JPY |
| Cost of sales | CurrentYearDuration | 2719711000 | JPY |
| Gross profit | Prior1YearDuration | 1460040000 | JPY |
| Gross profit | CurrentYearDuration | 1781134000 | JPY |
| Selling general and administrative expenses | Prior1YearDuration | 1014919000 | JPY |
| Selling general and administrative expenses | CurrentYearDuration | 1401483000 | JPY |
| Operating income | Prior1YearDuration | 445120000 | JPY |
| Operating income | CurrentYearDuration | 379650000 | JPY |
| Interest and dividends income noi | Prior1YearDuration | 690000 | JPY |
| Interest and dividends income noi | CurrentYearDuration | 841000 | JPY |
| Gain on forfeiture of unclaimed dividends noi | Prior1YearDuration | 72000 | JPY |
| Gain on forfeiture of unclaimed dividends noi | CurrentYearDuration | 53000 | JPY |
| Reversal of allowance for doubtful accounts noi | Prior1YearDuration | － | JPY |
| Reversal of allowance for doubtful accounts noi | CurrentYearDuration | 729000 | JPY |
| Insurance income noi | Prior1YearDuration | 267000 | JPY |
| Insurance income noi | CurrentYearDuration | 3180000 | JPY |
| Foreign exchange gains noi | Prior1YearDuration | 8620000 | JPY |
| Foreign exchange gains noi | CurrentYearDuration | 45190000 | JPY |
| Other noi | Prior1YearDuration | 4667000 | JPY |
| Other noi | CurrentYearDuration | 7046000 | JPY |
| Non operating income | Prior1YearDuration | 14319000 | JPY |
| Non operating income | CurrentYearDuration | 57043000 | JPY |
| Interest expenses noe | Prior1YearDuration | 1974000 | JPY |
| Interest expenses noe | CurrentYearDuration | 3026000 | JPY |
| Provision of allowance for doubtful accounts noe | Prior1YearDuration | 619000 | JPY |
| Provision of allowance for doubtful accounts noe | CurrentYearDuration | － | JPY |
| Expense of restricted shares noe | Prior1YearDuration | 5775000 | JPY |
| Expense of restricted shares noe | CurrentYearDuration | － | JPY |
| Loss on investments in partnership noe | Prior1YearDuration | 732000 | JPY |
| Loss on investments in partnership noe | CurrentYearDuration | 1392000 | JPY |
| Other noe | Prior1YearDuration | 761000 | JPY |
| Other noe | CurrentYearDuration | 525000 | JPY |
| Non operating expenses | Prior1YearDuration | 9862000 | JPY |
| Non operating expenses | CurrentYearDuration | 4944000 | JPY |
| Ordinary income | Prior1YearDuration | 449577000 | JPY |
| Ordinary income | CurrentYearDuration | 431749000 | JPY |
| Gain on negative goodwill ei | Prior1YearDuration | 84683000 | JPY |
| Gain on negative goodwill ei | CurrentYearDuration | － | JPY |
| Gain on sales of noncurrent assets ei | Prior1YearDuration | － | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |